SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Hrkach Jeff (Last) (First) (Middle) C/O BIND THERAPEUTICS, INC. 325 VASSAR STREET (Street) CAMBRIDGE MA 02139 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 09/19/2013	3. Issuer Name and Ticker or Trading Symbol BIND Therapeutics, Inc [ BIND ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) SVP, Technology, R&D	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	33,282	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	(1)	05/08/2018	Common Stock	20,305(1)	$1.21	D
Employee Stock Option (right to buy)	(2)	05/04/2019	Common Stock	13,358(2)	$1.21	D
Employee Stock Option (right to buy)	(3)	02/18/2020	Common Stock	21,374(3)	$1.21	D
Employee Stock Option (right to buy)	(4)	04/25/2021	Common Stock	26,717(4)	$1.63	D
Employee Stock Option (right to buy)	(5)	04/23/2022	Common Stock	26,717(5)	$2.52	D
Employee Stock Option (right to buy)	(6)	04/22/2023	Common Stock	15,593(6)	$2.78	D

Explanation of Responses:

1. On May 9, 2008, the reporting person was granted an option to purchase 26,717 shares of common stock. Beginning on March 7, 2008, the option is immediately exercisable and vests 25% after one year and in 36 equal monthly installments thereafter. On August 29, 2013, the reporting person exercized the option with respect to 6,412 shares.

2. Beginning on March 1, 2009, the option is immediately exercisable and vests 25% after one year and in 36 equal monthly installments thereafter.

3. Beginning on January 11, 2010, the option vests 25% after one year and in 36 equal monthly installments thereafter.

4. Beginning on March 1, 2011, the option vests 25% after one year and in 36 equal monthly installments thereafter.

5. Beginning on March 1, 2012, the option vests 25% after one year and in 36 equal monthly installments thereafter.

6. Beginning on April 1, 2013, the option vests 25% after one year and in 36 equal monthly installments thereafter.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Andrew Hirsch, attorney-in-fact	09/19/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.